The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular (CV) risk markers. In this study our aim was to assess the effects of six months treatment with liraglutide 1.8 mg od on obesity, and CV risk markers, particularly platelet function, in young obese w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Endocr Disord
Asıl Yazarlar: Kahal, Hassan, Aburima, Ahmed, Ungvari, Tamas, Rigby, Alan S, Coady, Anne M, Vince, Rebecca V, Ajjan, Ramzi A, Kilpatrick, Eric S, Naseem, Khalid M, Atkin, Stephen L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389314/
https://ncbi.nlm.nih.gov/pubmed/25880805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-015-0005-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller